Mécanismes de résistance à la chimiothérapie
作者： M. Campone , E. Bourbouloux , D. Berton-Rigaud , A. Le Pourhiet , S. Sadot
DOI: 10.1007/978-2-287-72615-6_14
关键词:
摘要: Le developpement de mecanisme resistance par la tumeur est un obstacle majeur l’efficacite a chimiotherapie. Ces mecanismes sont complexes et multifactoriels. Ils le reflet du polymorphisme (instabilite genomique mutations).
springer.com
core.ac.uk
sci-hub.se 参考文章(77)
Norman Sládek, Rahn Kollander, Lakshmaiah Sreerama, David Kiang, Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemotherapy and Pharmacology. ,vol. 49, pp. 309- 321 ,(2002) , 10.1007/S00280-001-0412-4
Hilary Thomas, Helen M. Coley, Overcoming Multidrug resistance in cancer: An update on the clinical strategy of inhibiting P-glycoprotein Cancer Control. ,vol. 10, pp. 159- 165 ,(2003) , 10.1177/107327480301000207
Richard Gorlick, Joseph R. Bertino, Clinical Pharmacology and Resistance to Dihydrofolate Reductase Inhibitors Humana Press. pp. 37- 57 ,(1999) , 10.1007/978-1-59259-725-3_3
Rajesh Krishna, Lawrence D Mayer, Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. European Journal of Pharmaceutical Sciences. ,vol. 11, pp. 265- 283 ,(2000) , 10.1016/S0928-0987(00)00114-7
D S Hawkins, G W Demers, D A Galloway, Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Research. ,vol. 56, pp. 892- 898 ,(1996)
Bernard Monsarrat, Michelle Sonnier, Michel Wright, Isabelle Royer, Thierry Cresteil, Metabolism of Docetaxel by Human Cytochromes P450: Interactions with Paclitaxel and Other Antineoplastic Drugs Cancer Research. ,vol. 56, pp. 58- 65 ,(1996)
Jane A. Plumb, Julieann Sludden, Robert Brown, Stanley B. Kaye, Gordon Strathdee, Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Research. ,vol. 60, pp. 6039- 6044 ,(2000)
Hua Yu, Richard Jove, The STATs of cancer — new molecular targets come of age Nature Reviews Cancer. ,vol. 4, pp. 97- 105 ,(2004) , 10.1038/NRC1275
D. Paul Harkin, Daniel B. Longley, John Boyer, Tariq Latif, Pamela Maxwell, Patrick G. Johnston, Maria Lynch, Paul R. Ferguson, Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies Clinical Cancer Research. ,vol. 7, pp. 3533- 3539 ,(2001)
K. W. Kohn, D. J. Rivet, A. J. Fornace, Qimin Zhan, M. L. Smith, Saijun Fan, P. M. O'connor, D. Duba, Disruption of p53 Function Sensitizes Breast Cancer MCF-7 Cells to Cisplatin and Pentoxifylline Cancer Research. ,vol. 55, pp. 1649- 1654 ,(1995)